Global Rheumatic Disorders Drugs Market Grow at (CAGR) of 4.46% to $80.04 billion in 2024

Global Rheumatic Disorders Drugs Market to 2024 research report covers key diseases of rheumatic disorders, market size, therapy area overview, etiology, Epidemiology Patterns and Forecasts - Prevalence and Patient Segmentation and key marketed products.

Pune, India - February 12, 2019 /MarketersMedia/ —

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry research report added to ReportsnReports online database.
The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be developed.

Get Discount on Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854866

This report covers all rheumatic disorders, but there is a particular focus on five key diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis, as these conditions have the largest pipelines within the therapy area.

The market size for rheumatic disorder therapeutics was $58.97 billion in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 4.46% to $80.04 billion in 2024.

Scope

- How is the rheumatic disorders market landscape expected to change?
- Which drugs will face patent expiry, biosimilar competition and decreasing revenue over the forecast period?
- Overall, there are 1,069 products in the rheumatic disorder pipeline, how does the composition of the pipeline compare with that of the existing market?
- Which molecular targets are most prominent within the pipeline and how do the key indications differ in terms of their pipeline composition?
- The market size for rheumatic disorder therapeutics is expected to grow, from $58.97 billion in 2017 to $80.04 billion in 2024, at a CAGR of 4.46%. Which products will contribute to market growth most, and which will achieve blockbuster status?
- What types of companies are involved in the rheumatic disorder therapy area?
- Will the current market leaders retain their dominance over the forecast period?
- How many strategic consolidations have been completed in the past decade and which types of assets attract the largest deal values?

Reasons to Buy:
This report will allow you to -
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis for the five key indications
- Understand how the patent expiries of the key, blockbuster anti-TNF drugs will affect the Rheumatic Disorder Drug Market
- Identify trends and developments in the rheumatic disorder pipeline and consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates
- Identify which two drug classes will see particularly strong market growth over the forecast period
- See how or if the companies marketing anti-TNF drugs facing patent expiry will be able to offset biosimilar erosion
- Identify commercial opportunities in the rheumatic disorder deal landscape by analyzing trends in licensing and co-development deals

Direct Purchase of Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854866

Table of Contents:
1. Introduction
2. Key Marketed Products
3. Pipeline Landscape Assessment
4. Multi-scenario Market Forecast to 2024
5. Company Analysis and Positioning
6. Strategic Consolidations
7. Appendix

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854866-global-rheumatic-disorders-drugs-market-to-2024-increased-uptake-of-il-inhibitors-and-jak-inhibitors-to-drive-growth-as-tnf-inhibitors-face-patent-expiry.html

Source URL: https://marketersmedia.com/global-rheumatic-disorders-drugs-market-grow-at-cagr-of-446-to-8004-billion-in-2024/481750

Source: MarketersMedia

Release ID: 481750

More News From Entertainment - The World Insiders

'Empire' actor goes from victim to accused felon in 3 weeks

Feb 21, 2019

CHICAGO — The whispers about "Empire" actor Jussie Smollett started with reports that he had not fully cooperated with police after telling authorities he was attacked in Chicago by two men who hurled racist, anti-gay slurs and looped a rope around his neck. Then detectives in a city bristling with surveillance cameras could not find video of the beating. Later, two brothers were taken into custody for questioning but were released after two days, with police saying they were no longer suspects. Following three weeks of mounting suspicions, Smollett was charged Wednesday with making a false police report, a charge...

Michael Jackson accusers detail road to 'Leaving Neverland'

Feb 21, 2019

PARK CITY, Utah — Wade Robson and James Safechuck didn't know what to think when the lights went up after the first public screening of "Leaving Neverland" late last month at the Sundance Film Festival. In the 236-minute documentary that will air in two parts on HBO and Britain's Channel 4 in March, both describe, in harrowing detail, how they say Michael Jackson sexually abused them as boys. It was the second time they'd seen it and the first with an audience. At intermission director Dan Reed even wondered whether or not they were going to be able to make...

Ego, publicity at stake when stars and TV critics meet

Feb 21, 2019

PASADENA, Calif. — Jerrod Carmichael, lamenting what he called the "terrible" state of TV comedy, asked his audience if they'd seen some of it. Staring back at the comedian was a hotel ballroom filled with journalists whose job it is to cover television. "I think they see all of it," helpfully offered Ramy Youssef, his fellow producer and star of their new Hulu sitcom. "Poor y'all," Carmichael said, a sympathetic coda to a semiannual event in which broadcast networks, cable channels and streaming platforms parade the shows and stars they hope will get attention from the 250 members of the...

Brothers in Smollett case are bodybuilders, aspiring actors

Feb 21, 2019

CHICAGO — An attorney representing the brothers at the center of an investigation into the attack reported by Jussie Smollett said Wednesday that her clients "manned up" and testified in front of a grand jury, before prosecutors charged the "Empire" actor with filing a false police report. Gloria Schmidt spoke to reporters outside a Chicago courthouse where the brothers met with the grand jury, which was collecting evidence in the case. Without providing details, she said the two men accepted money from Smollett and wanted to come clean. She said they weren't motivated by any promises from prosecutors. "There was...

'Empire' actor charged with making false police report

Feb 21, 2019

CHICAGO — "Empire" actor Jussie Smollett was charged Wednesday with making a false police report when he said he was attacked in downtown Chicago by two men who hurled racist and anti-gay slurs and looped a rope around his neck, police said. Police spokesman Anthony Guglielmi said prosecutors charged Smollett with felony disorderly conduct, an offense that could bring one to three years in prison and force the actor to pay for the cost of the investigation into his report of a Jan. 29 beating. Authorities were trying to get in touch with Smollett's attorneys to "negotiate a reasonable surrender,"...

About Us

The World Insiders brings you exclusive coverage from across the globe in a timely, easy to consume format sourced directly from our regional media partners.

Contact us: sales[at]theworldinsiders.com

Subscribe Now!